In this systematic review and meta-analysis, the strength of evidence was limited by the small number of studies, which suggests that future research should seek to investigate whether PD-L1 expression on immune cells is associated with survival in patients with HNSCC undergoing curative therapy. Here, CD274 is linked to head and neck squamous cell carcinoma.